My Companies
Notification
Account
The Board will meet on 3 September 2026 to consider and evaluate raising funds through equity shares, warrants or other securities via preferential issue, private placement or other permissible routes, subject to approvals. No amount, pricing, record date or ex-date has been disclosed.
Archit Organosys Withdraws Preferential Share Swap For Archit Life Science Acquisition
Archit Organosys Approves 92.2% Archit Life Science Acquisition Via Share Swap
Archit Organosys Approves 92.2% Archit Life Science Acquisition Via Share Swap
Archit Organosys Schedules Board Meeting To Consider Equity Fund Raise